Albert David Limited

NSE ALBERTDAVD.NS

Albert David Limited Price to Earnings Ratio (P/E) on February 06, 2025: 8.62

Albert David Limited Price to Earnings Ratio (P/E) is 8.62 on February 06, 2025, a -60.92% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Albert David Limited 52-week high Price to Earnings Ratio (P/E) is 22.21 on February 07, 2024, which is 157.75% above the current Price to Earnings Ratio (P/E).
Albert David Limited 52-week low Price to Earnings Ratio (P/E) is 8.09 on June 04, 2024, which is -6.15% below the current Price to Earnings Ratio (P/E).
Albert David Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 11.13.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NSE: ALBERTDAVD.NS

Albert David Limited

CEO	Mr. Umesh Manohar Kunte
IPO Date	June 14, 2016
Location	India
Headquarters	Gillander House
Employees	1,497
Sector	Consumers Staples
Industries Personal Care Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Eyewear Glass Pharmaceuticals Plastics

Description

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries. The company was incorporated in 1938 and is headquartered in Kolkata, India.

Key trends

Past 5 years